Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Ultrasensitive Detection of Human Chorionic Gonadotropin Using Frequency Locked Microtoroid Optical Resonators.

Ozgur E, Roberts KE, Ozgur EO, Gin AN, Bankhead JR, Wang Z, Su J.

Anal Chem. 2019 Sep 17;91(18):11872-11878. doi: 10.1021/acs.analchem.9b02630. Epub 2019 Aug 23.

PMID:
31415150
2.

The origin of exosomal miR-1246 in human cancer cells.

Xu YF, Hannafon BN, Khatri U, Gin A, Ding WQ.

RNA Biol. 2019 Jun;16(6):770-784. doi: 10.1080/15476286.2019.1585738. Epub 2019 Mar 23.

PMID:
30806147
3.

Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells.

Hannafon BN, Gin AL, Xu YF, Bruns M, Calloway CL, Ding WQ.

Cell Commun Signal. 2019 Feb 19;17(1):13. doi: 10.1186/s12964-019-0325-7.

4.

A combined fractional flow reserve and optical coherence tomography approach to guide coronary artery bypass grafting: A pilot study.

Fracassi F, Sugiyama T, Yamamoto E, Ghoshhajra B, Gin A, Albaghdadi M, Lee H, Melnitchouk S, Sundt TM, Jang IK.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):997-1000. doi: 10.1016/j.jtcvs.2018.05.037. Epub 2018 Jun 2. No abstract available.

PMID:
29960717
5.

Correction to: Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.

Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2018 May;78(7):787. doi: 10.1007/s40265-018-0910-x.

PMID:
29748749
6.

Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.

Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, Lagacé-Wiens PRS, Walkty A, Denisuik A, Golden A, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9. Review. Erratum in: Drugs. 2018 May 10;:.

PMID:
29230684
7.

Resolving classic pityriasis rubra pilaris, mimicker of erythema gyratum repens.

Davenport R, Le ST, Gin A, Goh MS, Foley P.

Australas J Dermatol. 2018 Aug;59(3):232-233. doi: 10.1111/ajd.12752. Epub 2017 Nov 28. No abstract available.

PMID:
29192964
8.

Application of three hygrometers under different skin conditions in dogs: dry, moist and haired skin.

Momota Y, Shimada K, Minorikawa N, Gin A, Matsubara T, Nakamura Y, Katayama M, Sako T.

Vet Dermatol. 2017 Dec;28(6):554-e131. doi: 10.1111/vde.12477. Epub 2017 Sep 3.

PMID:
28868812
9.

Single chip lidar with discrete beam steering by digital micromirror device.

Smith B, Hellman B, Gin A, Espinoza A, Takashima Y.

Opt Express. 2017 Jun 26;25(13):14732-14745. doi: 10.1364/OE.25.014732.

PMID:
28789057
10.

Eczema exacerbation caused by Coxsackie virus A6.

Gin A, King E, Scardamaglia L, Orchard D.

Australas J Dermatol. 2018 Feb;59(1):64-65. doi: 10.1111/ajd.12677. Epub 2017 Jul 20. No abstract available. Erratum in: Australas J Dermatol. 2018 May;59(2):162. Scardamaglia E [corrected to Scardamaglia, L].

PMID:
28726324
11.

The effect of a herbal paste and oil extract on the lipid content of canine hair fibres.

Momota Y, Shimada K, Kadoya C, Gin A, Kobayashi J, Nakamura Y, Matsubara T, Sako T.

Vet Dermatol. 2017 Aug;28(4):337-e73. doi: 10.1111/vde.12428. Epub 2017 Mar 6.

PMID:
28261924
12.

Consensus statement for the treatment of infantile haemangiomas with propranolol.

Smithson SL, Rademaker M, Adams S, Bade S, Bekhor P, Davidson S, Dore A, Drummond C, Fischer G, Gin A, Grills C, Halbert A, Lokmic Z, McCahon E, Morgan VA, Murrell DF, Orchard D, Penington A, Purvis D, Relic J, Robertson S, Robinson AJ, Scardamaglia L, Su J, Tan S, Wargon O, Warren L, Wong LC, Zappala T, Phillips R.

Australas J Dermatol. 2017 May;58(2):155-159. doi: 10.1111/ajd.12600. Epub 2017 Mar 1.

PMID:
28251611
13.

Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia.

Zhanel GG, Hartel E, Adam H, Zelenitsky S, Zhanel MA, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty AJ, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2016 Dec;76(18):1737-1757. Review.

PMID:
27909995
14.

Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy.

Gin AL, Vergallo R, Minami Y, Ong DS, Hou J, Jia H, Soeda T, Hu S, Zhang S, Lee H, Yu B, Jang IK.

Coron Artery Dis. 2016 Dec;27(8):629-635.

PMID:
27468140
15.

Molecular Characterization of the Cytidine Monophosphate-N-Acetylneuraminic Acid Hydroxylase (CMAH) Gene Associated with the Feline AB Blood Group System.

Omi T, Nakazawa S, Udagawa C, Tada N, Ochiai K, Chong YH, Kato Y, Mitsui H, Gin A, Oda H, Azakami D, Tamura K, Sako T, Inagaki T, Sakamoto A, Tsutsui T, Bonkobara M, Tsuchida S, Ikemoto S.

PLoS One. 2016 Oct 18;11(10):e0165000. doi: 10.1371/journal.pone.0165000. eCollection 2016.

16.

Measurement of transepidermal water loss (TEWL) in cats with experimental skin barrier dysfunction using a closed chamber system.

Momota Y, Shimada K, Gin A, Matsubara T, Azakami D, Ishioka K, Nakamura Y, Sako T.

Vet Dermatol. 2016 Oct;27(5):428-e110. doi: 10.1111/vde.12361. Epub 2016 Aug 5.

PMID:
27492205
17.

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.

Zhanel GG, Cheung D, Adam H, Zelenitsky S, Golden A, Schweizer F, Gorityala B, Lagacé-Wiens PR, Walkty A, Gin AS, Hoban DJ, Karlowsky JA.

Drugs. 2016 Apr;76(5):567-88. doi: 10.1007/s40265-016-0545-8. Review.

PMID:
26863149
18.

Genetic variants of the unsaturated fatty acid receptor GPR120 relating to obesity in dogs.

Miyabe M, Gin A, Onozawa E, Daimon M, Yamada H, Oda H, Mori A, Momota Y, Azakami D, Yamamoto I, Mochizuki M, Sako T, Tamura K, Ishioka K.

J Vet Med Sci. 2015 Oct;77(10):1201-6. doi: 10.1292/jvms.15-0031. Epub 2015 May 10.

19.

Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Zhanel GG, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, Gorityala B, Lagacé-Wiens PR, Rubinstein E, Walkty A, Gin AS, Gilmour M, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2015 Feb;75(3):253-70. doi: 10.1007/s40265-015-0352-7. Review.

PMID:
25673021
20.

Comprehensive evaluation of culture-negative endocarditis with use of cardiac and 4-dimensional-flow magnetic resonance imaging.

Thadani SR, Dyverfeldt P, Gin A, Chitsaz S, Rao RK, Hope MD.

Tex Heart Inst J. 2014 Jun 1;41(3):351-2. doi: 10.14503/THIJ-12-2651. eCollection 2014 Jun. No abstract available.

21.

Spontaneous cutaneous endometriosis of the umbilicus.

Gin TJ, Gin AD, Gin D, Pham A, Cahill J.

Case Rep Dermatol. 2013 Dec 21;5(3):368-72. doi: 10.1159/000357493. eCollection 2013 Sep.

22.

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagacé-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2014 Jan;74(1):31-51. doi: 10.1007/s40265-013-0168-2. Review.

PMID:
24352909
23.

Multidrug resistant miliary tuberculosis during infliximab therapy despite tuberculosis screening.

Gin A, Dolianitis C.

Australas J Dermatol. 2014 May;55(2):140-1. doi: 10.1111/ajd.12053. Epub 2013 May 29.

PMID:
23713793
24.

Ultrafast optical wide field microscopy.

Seo M, Boubanga-Tombet S, Yoo J, Ku Z, Gin AV, Picraux ST, Brueck SR, Taylor AJ, Prasankumar RP.

Opt Express. 2013 Apr 8;21(7):8763-72. doi: 10.1364/OE.21.008763.

PMID:
23571965
25.

Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

Zhanel GG, Lawson CD, Adam H, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Denisuik A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2013 Feb;73(2):159-77. doi: 10.1007/s40265-013-0013-7. Review.

PMID:
23371303
26.

Metoprolol-induced psoriatic nail disease.

Gin A, Gin D, Sinclair R.

Australas J Dermatol. 2013 Feb;54(1):59-60. doi: 10.1111/j.1440-0960.2012.00916.x. Epub 2012 Jun 22. Erratum in: Australas J Dermatol. 2013 Feb;54(1):77.

PMID:
22724586
27.

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.

Zhanel GG, Lawson CD, Zelenitsky S, Findlay B, Schweizer F, Adam H, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Lynch JP, Karlowsky JA.

Expert Rev Anti Infect Ther. 2012 Apr;10(4):459-73. doi: 10.1586/eri.12.25. Review.

PMID:
22512755
28.

Growth, defect formation, and morphology control of germanium-silicon semiconductor nanowire heterostructures.

Dayeh SA, Wang J, Li N, Huang JY, Gin AV, Picraux ST.

Nano Lett. 2011 Oct 12;11(10):4200-6. doi: 10.1021/nl202126q. Epub 2011 Aug 31.

PMID:
21877708
29.

How to read financial statements--Part 2: application.

Gin A.

J Okla State Med Assoc. 2011 Feb;104(2):53-60. No abstract available.

PMID:
21815322
30.

How to read financial statements--part 1: theory.

Gin A.

J Okla State Med Assoc. 2011 Jan;104(1):13-21. No abstract available.

PMID:
21446300
31.

Two-color multi-section quantum dot distributed feedback laser.

Naderi NA, Grillot F, Yang K, Wright JB, Gin A, Lester LF.

Opt Express. 2010 Dec 20;18(26):27028-35. doi: 10.1364/OE.18.027028.

PMID:
21196979
32.

Pseudoaneurysms of the mitral-aortic intervalvular fibrosa: survival without reoperation.

Gin A, Hong H, Rosenblatt A, Black M, Ristow B, Popper R.

Am Heart J. 2011 Jan;161(1):130.e1-5. doi: 10.1016/j.ahj.2010.09.013.

PMID:
21167344
33.

Few-layer graphene characterization by near-field scanning microwave microscopy.

Talanov VV, Del Barga C, Wickey L, Kalichava I, Gonzales E, Shaner EA, Gin AV, Kalugin NG.

ACS Nano. 2010 Jul 27;4(7):3831-8. doi: 10.1021/nn100493f.

PMID:
20536187
34.

New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

Zhanel GG, Calic D, Schweizer F, Zelenitsky S, Adam H, Lagacé-Wiens PR, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA.

Drugs. 2010 May 7;70(7):859-86. doi: 10.2165/11534440-000000000-00000. Review. Erratum in: Drugs. 2011 Mar 26;71(5):526.

PMID:
20426497
35.

H1N1 patients in ICU.

Gin A, Kumar A.

CMAJ. 2009 Oct 13;181(8):500. doi: 10.1503/cmaj.109-2022. No abstract available.

36.

Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus.

Zhanel GG, Sniezek G, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Rubinstein E, Gin AS, Hoban DJ, Karlowsky JA.

Drugs. 2009;69(7):809-31. doi: 10.2165/00003495-200969070-00003. Review.

PMID:
19441869
37.

Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.

Adam HJ, Hoban DJ, Gin AS, Zhanel GG.

Int J Antimicrob Agents. 2009 Jul;34(1):82-5. doi: 10.1016/j.ijantimicag.2009.02.002. Epub 2009 Apr 1.

PMID:
19342204
38.

Notice to Hospitals Regarding Ceftriaxone-Calcium Incompatibility: What's a Clinician to Do?

Gin A, Walker S.

Can J Hosp Pharm. 2009 Mar;62(2):157-8. No abstract available.

39.

Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.

Zhanel GG, Lam A, Schweizer F, Thomson K, Walkty A, Rubinstein E, Gin AS, Hoban DJ, Noreddin AM, Karlowsky JA.

Am J Clin Dermatol. 2008;9(4):245-54. Review.

PMID:
18572975
40.

Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.

Zhanel GG, Trapp S, Gin AS, DeCorby M, Lagacé-Wiens PR, Rubinstein E, Hoban DJ, Karlowsky JA.

Expert Rev Anti Infect Ther. 2008 Feb;6(1):67-81. doi: 10.1586/14787210.6.1.67. Review.

PMID:
18251665
41.

Clinical pharmaceutics and calcium-ceftriaxone.

Gin AS, Wheaton H, Dalton B.

Ann Pharmacother. 2008 Mar;42(3):450-1. doi: 10.1345/aph.1K410a. Epub 2008 Jan 29. No abstract available.

PMID:
18230702
42.

A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins?

Zhanel GG, Shroeder C, Vercaigne L, Gin AS, Embil J, Hoban DJ.

Can J Infect Dis. 2001 Nov;12(6):379-90.

43.

Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals.

Zhanel GG, Harding GK, Rosser S, Hoban DJ, Karlowsky JA, Alfa M, Kabani A, Embil J, Gin A, Williams T, Nicolle LE.

Can J Infect Dis. 2000 Jan;11(1):38-41.

44.

Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.

Gin A, Dilay L, Karlowsky JA, Walkty A, Rubinstein E, Zhanel GG.

Expert Rev Anti Infect Ther. 2007 Jun;5(3):365-83. Review.

PMID:
17547502
45.

A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections.

Zhanel GG, Fontaine S, Adam H, Schurek K, Mayer M, Noreddin AM, Gin AS, Rubinstein E, Hoban DJ.

Treat Respir Med. 2006;5(6):437-65. Review.

PMID:
17154673
46.

Ertapenem: review of a new carbapenem.

Zhanel GG, Johanson C, Embil JM, Noreddin A, Gin A, Vercaigne L, Hoban DJ.

Expert Rev Anti Infect Ther. 2005 Feb;3(1):23-39. Review.

PMID:
15757455
47.

The glycylcyclines: a comparative review with the tetracyclines.

Zhanel GG, Homenuik K, Nichol K, Noreddin A, Vercaigne L, Embil J, Gin A, Karlowsky JA, Hoban DJ.

Drugs. 2004;64(1):63-88. Review.

PMID:
14723559
48.

The ketolides: a critical review.

Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A, Embil JM, Gin AS, Douthwaite S, Hoban DJ.

Drugs. 2002;62(12):1771-804. Review.

PMID:
12149046
49.

A critical review of the fluoroquinolones: focus on respiratory infections.

Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, Smith H, Hoban DJ.

Drugs. 2002;62(1):13-59. Review. Erratum in: Drugs 2002;62(6):944.

PMID:
11790155
50.

Review of macrolides and ketolides: focus on respiratory tract infections.

Zhanel GG, Dueck M, Hoban DJ, Vercaigne LM, Embil JM, Gin AS, Karlowsky JA.

Drugs. 2001;61(4):443-98. Review.

PMID:
11324679

Supplemental Content

Support Center